Hemodialysis Opioid Prescription Effort (HOPE) Consortium
Part of NIH’s HEAL initiativeSM, the Hemodialysis Opioid Prescription Effort (HOPE) consortium addresses the prescripton of opioid medications in the ESRD hemodialysis population.
NIDDK Participation in NIH’s HEAL
In conjunction with NIH’s HEAL initiative, NIDDK proposed the Hemodialysis Opioid Prescription Effort (HOPE) consortium as a means of addressing opioid use within the U.S. End-Stage Renal Disease (ESRD) hemodialysis program.
The NIDDK will focus on
- pain in U.S. ESRD hemodialysis patients
- reduction of chronic opioid prescriptions for the ESRD population
- behaviorial, cognitive, and medical interventions to reduce the number of opioid prescriptions in ESRD hemodialysis patients
About the HOPE Consortium
The HOPE consortium is composed of eight Clinical Centers and a Scientific and Data Research Center. The consortium will deliver a pain coping skills intervention and will offer buprenorphine to reduce dependence on opioids in selected hemodialysis patients.
NIDDK offers the following funding opportunities for HOPE
HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) consortium
About NIH’s HEAL initiative
The National Institutes of Health HEAL (Helping to End Addiction Long-termSM) Initiative is a trans-agency effort focused on improving prevention and treatment strategies for opioid misuse and addiction, and enhancing pain management. Launched in April 2018 with funding from Congress, the opioid HEAL Initiative, brings new hope for people, families, and communities affected by the national public health crisis.
NIDDK Program Staff
Recent Funding OpportunitiesView More Recent Funding Opportunities
George M. O'Brien Kidney National Resource Centers (U54 - Clinical Trial Not Allowed)
National Coordinating Center for the George M. OBrien Kidney National Resource Centers (U24 - Clinical Trial Not Allowed)
NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
View related clinical trials from ClinicalTrials.gov.
Study sections conduct initial peer review of applications in a designated scientific area. View related study sections from the NIH's Center for Scientific Review.
NIDDK makes publicly supported resources, data sets, and studies available to researchers to accelerate the rate and lower the cost of new discoveries.
- Ancillary Studies to Major Ongoing Clinical Studies to extend our knowledge of the diseases being studied by the parent study investigators under a defined protocol or to study diseases and conditions not within the original scope of the parent study but within the mission of the NIDDK.
- NIDDK Central Repository for access to clinical resources including data and biospecimens from NIDDK-funded studies.
- NIDDK Information Network (dkNET) for simultaneous search of digital resources, including multiple datasets and biomedical resources relevant to the mission of the NIDDK.
Additional Research Programs
NIDDK supports the training and career development of medical and graduate students, postdoctoral fellows, and physician scientists through institutional and individual grants.Learn about NIDDK Research Training Programs
The NIDDK offers and participates in a variety of opportunities for trainees and researchers from communities underrepresented in the biomedical research enterprise. These opportunities include travel and scholarship awards, research supplements, small clinical grants, high school and undergraduate programs, and a network of minority health research investigators.Learn about NIDDK Diversity Programs
NIDDK participates in the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. These programs support innovative research conducted by small businesses that has the potential for commercialization.Learn about NIDDK Small Business Programs
Human Subjects Research
NIDDK provides funding for pivotal clinical research, from preliminary clinical feasibility to large multi-center studies.Learn about Human Subjects Research
NIDDK provides funding opportunities and resources to encourage translation of basic discoveries into novel therapeutics.Learn about NIDDK Translational Research Opportunities